Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
LakePharma has opened a new office in Dallas, Texas.
read more
3P Biopharmaceuticals (3P) announced Keensight Capital as its new major investor.
read more
Starting in July, the commercial brand for Eurofins Alphora will be Eurofins CDMO, falling under the CDMO umbrella in conjunction with Eurofins Amatsigroup.
read more
Novadoz, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approval for their generic version of Pregabalin capsules.
read more
Cytel announced that it will launch East On Demand™ at the annual Joint Statistical Meetings (JSM) 2019.
read more
Parexel announced the expansion of its capabilities through a new Hong Kong presence established by its healthcare consulting Health Advances subsidiary.
read more
Penta ID Innovation and CROMSOURCE announced their partnership focused on improving drug development for pediatric patients.
read more
McKesson Corporation has opened a new distribution center in Puyallup, Washington – 35 miles south of Seattle.
read more
Quotient Sciences and Permira announced a company backed by the Permira Funds has signed a definitive agreement to acquire a majority stake in Quotient.
read more
ICON announced the appointment of Julie O’Neill as a non-executive director.
read more
Jubilant Cadista Pharmaceuticals is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to the consumer level.
read more
STA Pharmaceutical announced its ASU in Shanghai and API process R&D and manufacturing facility in Changzhou, have successfully passed two inspections from the FDA.
read more
Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third ADC produced at the site.
read more
Ligand Pharmaceuticals has announced the signing of an agreement with Ab Initio Biotherapeutics whereby Ligand will acquire Ab Initio for $12 million in cash.
read more
Samsung Bioepis announced the FDA has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® (adalimumab).
read more